ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
1/1
2 files

Protein Capped Metal Nanoparticles Inhibits Tau Aggregation in Alzheimer’s Disease

preprint
submitted on 31.05.2019, 06:08 and posted on 31.05.2019, 18:21 by Absar Ahmad, Subashchandrabose Chinnathambi
The Alzheimer’s disease (AD) therapeutic research is yielding large number of potent molecules. The nanoparticle-based therapeutics against the protein aggregation in AD is also taking a lead especially with amyloid beta as a primary target. In this work, we have screened for first time, the protein capped (PC) metal nanoparticles for their potency in inhibiting Tau aggregation in vitro. We present a novel function of PC-CdS nanoparticles as a potent Tau aggregation inhibitor by fluorescence spectrometry, SDS-PAGE and Electron microscopy. We demonstrate that the biologically synthesized PC-metal nanoparticles, iron oxide and cadmium sulphide do not affect the viability of neuroblastoma cells. Moreover, PC-CdS nanoparticles show dual property of inhibition as well as disaggregation of Tau. Thus, the nanoparticles can take a lead as potent Tau aggregation inhibitors and can be modified for specific drug delivery due to very small size. This current work presents unprecedented strategy to design anti-Tau aggregation drugs, which provides interesting insights to understand the role of biological nanostructures in Alzheimer’s disease.

Funding

(DBT-HDDB))-BT/PR/15780/MED/30/1629/2015

CSIR-National Chemical Laboratory grant MLP029526 and CSIR-network project BSC0115

History

Email Address of Submitting Author

s.chinnathambi@ncl.res.in

Institution

CSIR National Chemical Laboratory

Country

India

ORCID For Submitting Author

0000-0002-5468-2129

Declaration of Conflict of Interest

The authors declare no competing financial interest.

Version Notes

Protein Capped Metal Nanoparticles Inhibits Tau Aggregation in Alzheimer’s disease

Exports